Direct Oral Anticoagulants (DOACs): Challenges and Decisions
Tracking # 20-1364498
Course overview
Thrombotic disorders place a substantial burden on patients and the healthcare system, contributing to significant morbidity and mortality worldwide. Anticoagulant therapy plays a central role in the prevention and treatment of thromboembolic disease, yet its use requires careful clinical judgment given the competing risks of thrombosis and bleeding. Within interdisciplinary care teams, healthcare professionals collaborate to evaluate anticoagulation options and identify situations in which DOAC therapy is indicated, inappropriate, or requires modification. A shared understanding of the similarities and differences among DOAC agents is essential for optimizing therapy, reducing preventable adverse events, supporting safe transitions of care, and supporting informed discussions with patients and other members of the healthcare team.
Subject areas
This course counts toward the state boards and subject areas below.